Posts Tagged ‘technology’
BioElectronics Technology More Effective Than Extra Strength Tylenol(R) In Reducing Muscle Soreness In Clinical Study
BioElectronics Corp. (PINKSHEETS: BIEL) announced that its disposable drug-free anti-inflammatory devices proved to be significantly more effective than acetaminophen in a clinical study of Delayed Onset Muscle Soreness (DOMS). The study tested the effectiveness of ActiPatch® Therapy versus acetaminophen in reducing the pain of Delayed Onset Muscle Soreness, a condition associated with increased physical exertion.
Military Approves H1N1 Testing With Idaho Technology JBAIDS
Idaho Technology’s Joint Biological Agent Identification and Diagnostic System (JBAIDS) has been approved by the military to run tests for the H1N1 virus. Deployed across the globe, including in Iraq and Afghanistan, by all four branches of the military, the JBAIDS instrument will be used to test military personnel and their families for Influenza A, swine flu A and H1 swine flu in less than an hour. More traditional means of testing can take days to deliver results.
Why simulation can be efficient: on the preconditions of efficient learning in complex technology based practices.
Background:It is important to demonstrate learning outcomes of simulation in technology based practices, such as in advanced health care. Although many studies show skills improvement and self-reported change to practice, there are few studies demonstrating patient outcome and societal efficiency.The objective of the study is to investigate if and why simulation can be effective and efficient in a hi-tech health care setting. This is important in order to decide whether and how to design simulation scenarios and outcome studies.Methods:Core theoretical insights in Science and Technology Studies (STS) are applied to analyze the field of simulation in hi-tech health care education. In particular, a process-oriented framework where technology is characterized by its devices, methods and its organizational setting is applied.Results:The analysis shows how advanced simulation can address core characteristics of technology beyond the knowledge of technology’s functions. Simulation’s ability to address skilful device handling as well as purposive aspects of technology provides a potential for effective and efficient learning. However, as technology is also constituted by organizational aspects, such as technology status, disease status, and resource constraints, the success of simulation depends on whether these aspects can be integrated in the simulation setting as well. This represents a challenge for future development of simulation and for demonstrating its effectiveness and efficiency.Conclusion:Assessing the outcome of simulation in education in hi-tech health care settings is worthwhile if core characteristics of medical technology are addressed. This challenges the traditional technical versus non-technical divide in simulation, as organizational aspects appear to be part of technology’s core characteristics.
Second U.S. Independent Laboratory Confirms That Oculus Innovative Sciences’ Microcyn(R) Technology Effective At Inactivating H1N1 Swine Flu
Oculus Innovative Sciences, Inc. (NASDAQ:OCLS), a healthcare company that develops, manufactures and markets a family of products based upon the Microcyn? Technology platform, which includes new formulations intended to reduce the use of antibiotics by preventing or treating infections including those caused by bacteria and viruses, has confirmed the effectiveness of Microcyn? Technology at inactivating the H1NI Swine Influenza A.
VaxInnate Reports Positive Results From Preclinical Testing Of Swine Flu Vaccine Developed Using Novel Technology
VaxInnate Corporation today reported positive preclinical results for a recombinant swine flu vaccine it developed in less than three weeks, making it one of the first companies in the world to begin testing a vaccine that could help halt the spread of the swine flu pandemic. Preclinical studies in mice suggest that VaxInnate’s recombinant swine flu vaccine could provide protection against the pandemic H1N1 influenza A swine flu strain,
HHS Will Release Guidance On ‘Meaningful Use’ Of Health Information Technology This Summer, Blumenthal Says
HHS soon will issue guidance and specifications on the definition of “meaningful use” of health information technology, National Coordinator for Health IT David Blumenthal said on Friday, CongressDaily reports (Noyes, CongressDaily, 5/8).
Prevalence Of ‘Silent’ Heart Attacks Revealed With New Imaging Technology
So-called “silent” heart attacks may be much more common than previously believed, according to researchers. Studies show that each year, nearly 200,000 people in the US suffer a heart attack but may not realize it. These “silent” heart attacks aren’t noted because they don’t cause any pain — or at least any pain that patients believe is related to their heart — and they don’t leave behind any telltale irregularities on electrocardiograms.
Technology Enables Ambulatory Surgery Centers To Meet New CMS Regulatory Guidelines On Patient Rights
Effective May 18, 2009 a new set of guidelines from the Centers for Medicare & Medicaid Services (CMS) will take effect. Section 416.50 requires Ambulatory Surgery Centers (ASCs) to provide patients or their representatives with written notice of patient’s rights, disclosure of ownership, advance directives and informed consent in advance of the procedure.
Technology Could Improve Vaccines For Both Seasonal Flu And Bird Flu
A new computerized method of testing could help world health officials better identify flu vaccines that are effective against multiple strains of the disease. Rice University scientists who created the method say tests of data from bird flu and seasonal flu outbreaks suggest their method can better gauge the efficacy of proposed vaccines than can tests used today.
Unique InterX(R) Neurostimulation Technology Available From Mobilis
New from Mobilis? Healthcare is the advanced InterX non-invasive, interactive neurostimulation system, for the relief and management of acute and chronic pain. Offering a unique combination of neurostimulation, myofascial release, therapeutic exercise and trigger point therapy, the technology is available in the InterX 5002 professional model for clinical and sports therapy applications and the InterX 1000 personal device for home use.
Rx Drug Compare
Translator
By N2H